Aglaia BioMedical Ventures combines its focus on oncology with disciplined financing and a hands-on involvement – up to the level of strategic and operational management – to ensure focus on value creation and capital efficiency: keys to success for early stage companies. New additions to our team should bring complimentary scientific as well as clinical, legal, financial and business development expertise to the company.
If you are interested, please send us your details and a CV to firstname.lastname@example.org.
Modra Pharmaceuticals Expands Management Team and Provides Corporate Update
ISA Pharmaceuticals’ Chief Scientific Officer Prof. Cornelis Melief Receives ESMO Immuno-Oncology Award 2018